$20.97
-0.45-2.10%
At close: -
$20.97
0.000.00%
After Hours: Jan 17, 4:31 PM EDT
Instil Bio reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Instil Bio using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-13 | $-2.55 | $-2.10 | -21.4 % |
Q2 | 2024-08-13 | $-2.29 | $-2.98 | 23.2 % |
Q1 | 2024-05-10 | $-2.39 | $-2.23 | -7.17 % |
Q4 | 2024-03-21 | $-1.26 | $-2.85 | 55.8 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2023-03-31 | $0 | $500.00K | -100.0 % |
Instil Bio (TIL) is scheduled to report earnings on March 20, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.
The Actual EPS was $-2.55, which missed the estimate of $-2.10.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.